EyeGate Pharmaceuticals Company
EyeGate Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.
Technology:
Others
Industry:
PharmTech
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
1998-01-01
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
82372564
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership